FDA Approves Drug For Dogs
April 1, 2010
The U.S. Food and Drug Administration has approved Roseland, N.J.-based Intervet’s new animal drug application for the veterinary prescription use of Posatex (orbifloxacin, mometasone furoate monohydrate, and posaconazole) Otic Suspension for the treatment of otitis externa in dogs. Effective as of April 1, 2010, this drug is for treatment of otitis externa associated with susceptible… Continue reading...